From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy

Papers of special note have been highlighted as: •• of considerable interest

References

• 1. Lahner E, Esposito G, Pilozzi E et al. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand. J. Gastroenterol. 50(7), 856–865 (2015).
  Medline CASGoogle Scholar
• 2. Xiao S, Li S, Zhou L, Jiang W, Liu J. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis. J. Gastroenterol. 54(3), 226–237 (2019).
  MedlineGoogle Scholar
• 3. Brito-Gonçalves G, Libânio D, Marcos P et al. Clinicopathologic characteristics of patients with gastric superficial neoplasia and risk factors for multiple lesions after endoscopic submucosal dissection in a western country. GE Port. J. Gastroenterol. 27(2), 76–89 (2020).
  MedlineGoogle Scholar
• 4. Tang X-D, Zhou L-Y, Zhang S-T et al. Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia. Chin. J. Integr. Med. 22(1), 9–18 (2016).
  Medline CASGoogle Scholar
• 5. Estifan E, Cavanagh Y, Grossman MA. Hybrid argon plasma coagulation for treatment of gastric intestinal metaplasia. Cureus 12, e7427 (2020).
  MedlineGoogle Scholar
• 6. Banks M, Graham D, Jansen M et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 68(9), 1545–1575 (2019).
  MedlineGoogle Scholar
• 7. Pimentel-Nunes P, Libânio D, Marcos-Pinto R et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Port. Endoscopy 51(4), 365–388 (2019).
  MedlineGoogle Scholar
• 8. Terasawa T, Nishida H, Kato K et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in eastern Asians: a systematic review and meta-analysis. PLoS ONE 9(10), e109783 (2014).
  MedlineGoogle Scholar
• 9. Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer 21(4), 579–587 (2018).
  MedlineGoogle Scholar
• 10. Wei N, Mulmi Shrestha S, Shi RH. Markers of gastric intestinal metaplasia under digital chromoendoscopy: systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 33(4), 470–478 (2021).
  MedlineGoogle Scholar
• 11. Uedo N, Ishihara R, Iishi H et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 38(8), 819–824 (2006).
  Medline CASGoogle Scholar
• 12. Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig. Endosc. 27(7), 734–41 (2015).
  MedlineGoogle Scholar
• 13. Pimentel-Nunes P, Libânio D, Lage J et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 48(8), 723–730 (2016). •• Proposed the concept of endoscopic grading of gastric intestinal metaplasia (EGGIM) to identify areas of gastric intestinal metaplasia (GIM) using non-magnification digital chromoendoscopy and then carrried out risk stratification of patients with GIM, finding the method to be feasible and accurate, with narrow-band imaging (NBI), blue light imaging (BLI) and linked color imaging (LCI) all showing good operability.
  MedlineGoogle Scholar
• 14. Pezzoli A, Cifalà V, Matarese V et al. P.13.2 Do we really need biopsy to diagnose colorectal cancer? Dig. Liver Dis. 48(2), e189 (2016).
  MedlineGoogle Scholar
• 15. Lage J, Pimentel-Nunes P, Figueiredo PC et al. Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma: do we still need biopsies? Scand. J. Gastroenterol. 51(4), 501–506 (2016).
  MedlineGoogle Scholar
• 16. Marcos P, Brito-Gonçalves G, Libânio D et al. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the west? Gut 69(10), 1762–1768 (2020).
  MedlineGoogle Scholar
• 17. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20(10), 1161–1181 (1996).
  Medline CASGoogle Scholar
• 18. Whiting PF, Rutjes AWS, Westwood ME et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155(8), 529–536 (2011).
  MedlineGoogle Scholar
• 19. Chen H, Liu Y, Lu Y et al. Ability of blue laser imaging with magnifying endoscopy for the diagnosis of gastric intestinal metaplasia. Lasers Med. Sci. 33(8), 1757–1762 (2018).
  MedlineGoogle Scholar
• 20. Savarino E, Corbo M, Dulbecco P et al. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World. J. Gastroenterol. 19(17), 2668–2675 (2013).
  MedlineGoogle Scholar
• 21. Guo Y-T, Li Y-Q, Yu T et al. Diagnosis of gastric intestinal metaplasia with confocal laser endomicroscopy in vivo: a prospective study. Endoscopy 40(7), 547–553 (2008).
  MedlineGoogle Scholar
• 22. An JK, Song GA, Kim GH et al. Marginal turbid band and light blue crest, signs observed in magnifying narrow-band imaging endoscopy, are indicative of gastric intestinal metaplasia. BMC Gastroenterol. 12, 169 (2012).
  MedlineGoogle Scholar
• 23. Kanzaki H, Uedo N, Ishihara R et al. Comprehensive investigation of areae gastricae pattern in gastric corpus using magnifying narrow band imaging endoscopy in patients with chronic atrophic fundic gastritis. Helicobacter 17(3), 224–231 (2012).
  MedlineGoogle Scholar
• 24. Kawamura M, Abe S, Oikawa K et al. Topographic differences in gastric micromucosal patterns observed by magnifying endoscopy with narrow band imaging. J. Gastroenterol. Hepatol. 26(3), 477–483 (2011).
  MedlineGoogle Scholar
• 25. Gawron AJ, Shah SC, Altayar O et al. AGA technical review on gastric intestinal metaplasia – natural history and clinical outcomes. Gastroenterology 158, 705–731.e5 (2020).
  MedlineGoogle Scholar
• 26. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest. Endosc. 57(4), 498–504 (2003).
  MedlineGoogle Scholar
• 27. Yang J-M, Chen L, Fan Y-L et al. Endoscopic patterns of gastric mucosa and its clinicopathological significance. World. J. Gastroenterol. 9(11), 2552–2556 (2003).
  MedlineGoogle Scholar
• 28. Zhang G, Zheng J, Zheng L et al. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology. Scand. J. Gastroenterol. 56(1), 103–110 (2021).
  Medline CASGoogle Scholar
• 29. Esposito G, Pimentel-Nunes P, Angeletti S et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 51(6), 515–521 (2019).
  MedlineGoogle Scholar
• 30. Khashab MA, Kalloo AN. NOTES: current status and new horizons. Gastroenterology 142(4), 704–710.e1 (2012).
  MedlineGoogle Scholar
• 31. Xu M, Zhou W, Wu L et al. Artificial intelligence in the diagnosis of gastric precancerous conditions by image-enhanced endoscopy: a multicenter, diagnostic study (with video). Gastrointest. Endosc. 94(3), 540–548.e4 (2021).
  MedlineGoogle Scholar